Share
Share
Arbor Research Collaborative for Health, a Michigan-based 501(c)3 nonprofit corporation, is proud to announce the award of the General Services Administration (GSA) Multiple Award Schedule contract to its subsidiary, Arbor Research LLC under SINs 541611 and 541715.
Arbor Research LLC qualifies as a small business under the associated NAICS codes and will seek additional SINs as the organization evolves and expands its mission impact. The federal government has placed continued importance on expanding its contracting with small businesses to reach or exceed its small business goals; Arbor Research LLC looks forward to supporting these efforts.
“We are thrilled to achieve this designation and expand our ability to serve government clients,” said Christopher Spera, PhD, President and CEO of Arbor Research Collaborative for Health. “This award underscores our dedication to advancing health care through innovative research and strategic alliances. It allows us to expand our market beyond our traditional scope, which emphasizes and honors our mission of improving patient outcomes and shaping the future of health care policy.”
“Arbor’s growth over the years has been remarkable, and the GSA designation represents a significant step in expanding our reach beyond our traditional role, opening up new and exciting opportunities,” noted Chauncey R. Lynch, II, Chief Financial Officer, Arbor Research Collaborative for Health.
As pioneers in health care research, Arbor Research Collaborative for Health serves a diverse array of governmental, pharmaceutical, and private/foundation clients, illuminating new pathways in health care, driving progress and transformation across the industry. The unique structure of Arbor Research and Arbor Research LLC allows the organization to meet the needs of its expansive and diverse client base effectively.
Arbor Research Collaborative for Health is excited to announce a partnership with CSL Vifor to launch a multinational registry designed to capture real-world outcomes of difelikefalin (Kapruvia®), a newly-approved treatment for chronic kidney disease-associated pruritus (CKD-aP) in hemodialysis (HD) patients. Known as PARADIGM (PAn european Registry Addressing pruritus in DIalysis with a focus on Goal […]
The Health Resources and Services Administration (HRSA) has selected Arbor Research Collaborative for Health (Arbor Research) as one of 14 organizations who will lead the modernization of the Organ Procurement and Transplantation Network (OPTN). Arbor Research received one of the five initial efforts, focusing on improving patient safety and policy compliance systems and processes overseen […]
Arbor Research Collaborative for Health (Arbor Research) is proud to announce that its wholly-owned, small-business subsidiary, Arbor Research LLC, received its first competitive prime contract award. The award expands the organization’s 25-year history doing mission-impactful work in chronic disease and beyond. Arbor Research was awarded the National Cancer Institute (NCI) Center for Global Health (CGH) […]
A newly published article in the American Journal of Kidney Diseases, titled “Explaining International Trends in Mortality on Hemodialysis Through Changes in Hemodialysis Practices in the Dialysis Outcomes and Practice Patterns Study (DOPPS),” reveals significant findings on the factors contributing to improved patient survival rates among hemodialysis patients worldwide. The study, led by Arbor Research […]